Impact of the V0034CR 01B emollient on atopic dermatitis symptoms in children. A randomised, placebo-controlled, parallel-groups, double-blind study
Impact of the V0034CR 01B emollient on atopic dermatitis symptoms in children. A randomised, placebo-controlled, parallel-groups, double-blind study
Impact of the V0034CR 01B emollient on atopic dermatitis symptoms in children. A randomised, placebo-controlled, parallel-groups, double-blind study
Status
Status :
Completed
Type of study
Phase IV
Min. Age
2
Years old
Max. Age
7
Years old
Gender
All
Therapeutic area :
Dermatology
Disease :
Xerosis
Study medication :
Dexeryl®
Phase :
Phase IV
Start Date :
30 October 2008
End date :
23 May 2009
Study ID :
V0034 CR 402 1B
EudraCT/CTIS number :
2008-003485-25
Send by email